# Normothermic Liver Preservation Trial

> **NCT03089840** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 106 (actual)

## Conditions studied

- End Stage Liver Disease
- Liver Diseases

## Interventions

- **DEVICE:** OrganOx metra

## Key facts

- **NCT ID:** NCT03089840
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-24
- **Primary completion:** 2024-07-23
- **Final completion:** 2024-07-23
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03089840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03089840, "Normothermic Liver Preservation Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03089840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*